{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:14:05Z","timestamp":1790183645160,"version":"4.1.0"},"reference-count":58,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Palliative care improves quality of life (QoL) in advanced illnesses, but data in end-stage liver disease (ESLD) are limited. It is unknown whether palliative care delivered by hepatologists is effective when compared with palliative care specialists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the effectiveness of palliative care delivered by trained hepatologists with the care delivered by conventional palliative care specialists in improving QoL at 3 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This comparative effectiveness cluster randomized trial for US patients treated for ESLD in 19 US medical centers compared a palliative care intervention delivered by palliative care\u2013trained hepatologists (hepatologist group; 11 centers) with palliative care specialists (consultative group; 8 centers). Eligible patients were US adults with either decompensated cirrhosis or hepatocellular cancer who had a life expectancy of at least 6 months, had not received or scheduled liver transplantation, or had not received palliative care in the prior 3 months. Hepatologists in hepatologist group alone received primary palliative care training. Data collection occurred from January 2019 through June 2025; analysis was conducted from July to September 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Participants received 4 palliative care visits over 3 months delivered by either palliative care\u2013trained hepatologists or palliative care specialists, using a structured palliative care checklist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Superiority or a priori noninferiority of the effect of palliative care delivered by hepatologists vs palliative care specialists on change in QoL at 3 months, measured by the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) total score (higher scores indicating better QoL). Secondary outcomes included change in symptom burden, distress, depression, satisfaction from baseline to 3 months, and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 935 patients were enrolled (mean [SD] age, 63.0 [10.3] years; 275 female [29%]; 130 Hispanic ethnicity [14%]; 144 Black [15%], 736 White [79%]). From baseline to 3 months, QoL improved in both groups (adjusted mean: hepatologist, 8.01 [95% CI, 5.38 to 10.65]; consultative, 7.02 [95% CI, 4.34 to 9.71]; both\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Although superiority was not found in change in QoL, prespecified noninferiority analysis showed that the improvement in the hepatologist group was noninferior to the consultative group (adjusted mean difference, 0.98 [95% CI, \u22122.86 to 4.83];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.01). Symptom burden (adjusted mean difference, \u22127.52 [95% CI, \u22129.89 to \u22125.15] vs \u22125.31 [95% CI, \u22127.60 to \u22123.03]) and depression (adjusted mean difference, \u22121.18 [95% CI, \u22121.78 to \u22120.57] vs \u22120.90 [95% CI, \u22121.49 to \u22120.31]) improved in both groups, without significant between-group differences. Patient satisfaction improved more in the hepatologist group compared with the palliative care group (adjusted mean difference, 3.37 [95% CI, 2.24 to 4.49] vs 0.91 [95% CI, \u22120.15 to 1.96];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.002). Mortality at 3 months was similar in both groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This cluster trial found that palliative care delivered by trained hepatologists was comparable with palliative care delivered by palliative care specialists in improving QoL in patients with ESLD and was associated with greater improvement in patient satisfaction, demonstrating the effectiveness among enrolled patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.Gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT03540771?term=NCT03540771&amp;amp;amp;rank=1\">NCT03540771<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamainternmed.2026.0571","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:30:33Z","timestamp":1776094233000},"page":"677","source":"Crossref","is-referenced-by-count":8,"title":["Palliative Care Intervention for Patients With End-Stage Liver Disease"],"prefix":"10.1001","volume":"186","author":[{"given":"Manisha","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Medicine, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Navarro","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kosinski","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Taddei","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kalman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sidney","family":"Barritt IV","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Jakab","sequence":"additional","affiliation":[{"name":"Department of Medicine, West Haven VA Medical Center, West Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Serper","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Orman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University, Indianapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Balakrishnan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Rakoski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Loma Linda University, Loma Linda, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Rockey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Hunt","sequence":"additional","affiliation":[{"name":"Department of Medicine, VA Bronx Health Care, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roniel","family":"Cabrera","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Florida, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Aytaman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brooklyn VA Medical Center, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binu","family":"John","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Baffy","sequence":"additional","affiliation":[{"name":"Department of Medicine, VA Boston Health Care, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Nathan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Banner Health, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Tapper","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Roytman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, Fresno"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"McGuire","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hoppmann","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Woodrell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mount Sinai Health System, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bakitas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yue","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"Reeve","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Tantala","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Volk","sequence":"additional","affiliation":[{"name":"Department of Medicine, Baylor Scott & White Health, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ioi260012r1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"ioi260012r2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update.","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"ioi260012r3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"issue":"10308","key":"ioi260012r4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis.","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"ioi260012r6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/0269216318807051","article-title":"Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis.","volume":"33","author":"Peng","year":"2019","journal-title":"Palliat Med"},{"issue":"4","key":"ioi260012r7","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/hep.30336","article-title":"Frailty, psychoactive medications, and cognitive dysfunction are associated with poor patient-reported outcomes in cirrhosis.","volume":"69","author":"Tapper","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"ioi260012r8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cgh.2009.03.013","article-title":"Health-related quality of life predicts mortality in patients with advanced chronic liver disease.","volume":"7","author":"Kanwal","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"ioi260012r9","doi-asserted-by":"publisher","DOI":"10.1097\/CLD.0000000000000222","article-title":"The role of patient-reported outcomes in a patient-centered care model for managing chronic liver diseases.","volume":"23","author":"Verma","year":"2024","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"4","key":"ioi260012r10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.28717","article-title":"Balancing quality with quantity: the role of palliative care in managing decompensated cirrhosis.","volume":"64","author":"Langberg","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"ioi260012r11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.32618","article-title":"Patient-centered care: key elements applicable to chronic liver disease.","volume":"78","author":"Verma","year":"2023","journal-title":"Hepatology"},{"issue":"14","key":"ioi260012r12","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1001\/jama.299.14.1698","article-title":"Effectiveness of specialized palliative care: a systematic review.","volume":"299","author":"Zimmermann","year":"2008","journal-title":"JAMA"},{"issue":"20","key":"ioi260012r13","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2016.16840","article-title":"Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis.","volume":"316","author":"Kavalieratos","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"ioi260012r14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1089\/jpm.2022.0338","article-title":"Feasibility of a palliative care intervention within routine care of hepatocellular carcinoma: a pilot randomized controlled trial.","volume":"26","author":"Verma","year":"2023","journal-title":"J Palliat Med"},{"issue":"12","key":"ioi260012r15","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.cgh.2019.03.022","article-title":"Barriers to use of palliative care and advance care planning discussions for patients with end-stage liver disease.","volume":"17","author":"Ufere","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"ioi260012r16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jceh.2022.08.003","article-title":"Palliative care for patients with end-stage liver disease.","volume":"13","author":"Philips","year":"2023","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"ioi260012r17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-007451","article-title":"Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease.","volume":"5","author":"Valery","year":"2015","journal-title":"BMJ Open"},{"issue":"10","key":"ioi260012r18","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cgh.2017.01.030","article-title":"Palliative care and health care utilization for patients with end-stage liver disease at the end of life.","volume":"15","author":"Patel","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"ioi260012r19","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.jhep.2018.08.028","article-title":"Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals.","volume":"69","author":"Low","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"ioi260012r20","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1002\/hep.31226","article-title":"Nonhospice palliative care within the treatment of end-stage liver disease.","volume":"71","author":"Verma","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"ioi260012r21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1056\/NEJMra1404684","article-title":"Palliative care for the seriously ill.","volume":"373","author":"Kelley","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"ioi260012r22","first-page":"99","article-title":"A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses.","volume":"4","author":"Davis","year":"2015","journal-title":"Ann Palliat Med"},{"issue":"3","key":"ioi260012r23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrclinonc.2015.201","article-title":"Integrating palliative care into the trajectory of cancer care.","volume":"13","author":"Hui","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"13","key":"ioi260012r24","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJMp1215620","article-title":"Generalist plus specialist palliative care\u2013creating a more sustainable model.","volume":"368","author":"Quill","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"ioi260012r25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1089\/jpm.2020.0282","article-title":"Factors associated with the adoption and closure of hospital palliative care programs in the United States.","volume":"24","author":"Rogers","year":"2021","journal-title":"J Palliat Med"},{"issue":"4","key":"ioi260012r26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cgh.2020.11.027","article-title":"AGA clinical practice update on palliative care management in cirrhosis: expert review.","volume":"19","author":"Tandon","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"ioi260012r27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jhep.2023.06.018","article-title":"Palliative clinical trials in advanced chronic liver disease: challenges and opportunities.","volume":"79","author":"Verma","year":"2023","journal-title":"J Hepatol"},{"issue":"S1","key":"ioi260012r28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/jpm.2019.0121","article-title":"Introducing palliative care within the treatment of end-stage liver disease: the study protocol of a cluster randomized controlled trial.","volume":"22","author":"Verma","year":"2019","journal-title":"J Palliat Med"},{"issue":"12","key":"ioi260012r29","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1089\/jpm.2018.0431","article-title":"National consensus project clinical practice guidelines for quality palliative care guidelines.","volume":"21","author":"Ferrell","year":"2018","journal-title":"J Palliat Med"},{"issue":"10","key":"ioi260012r30","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MLR.0000000000002037","article-title":"Palliative care and advance care planning intervention fidelity monitoring: methods and lessons learned from PCORI-funded large-scale, pragmatic clinical trials.","volume":"62","author":"Verma","year":"2024","journal-title":"Med Care"},{"issue":"4","key":"ioi260012r31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/hep4.1849","article-title":"Palliative care always: hepatology\u2014virtual primary palliative care training for hepatologists.","volume":"6","author":"DeNofrio","year":"2022","journal-title":"Hepatol Commun"},{"issue":"9","key":"ioi260012r32","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1200\/JCO.2002.07.093","article-title":"Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire.","volume":"20","author":"Heffernan","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"ioi260012r33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation.","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"ioi260012r34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11136-006-9111-2","article-title":"Health-related quality of life: hepatocellular carcinoma, chronic liver disease, and the general population.","volume":"16","author":"Steel","year":"2007","journal-title":"Quality of Life Res"},{"issue":"4","key":"ioi260012r35","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000385","article-title":"The Edmonton Symptom Assessment System is a valid, reliable, and responsive tool to assess symptom burden in decompensated cirrhosis.","volume":"8","author":"Donlan","year":"2024","journal-title":"Hepatol Commun"},{"issue":"3","key":"ioi260012r36","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","article-title":"The Edmonton Symptom Assessment System 25 years later: past, present, and future developments.","volume":"53","author":"Hui","year":"2017","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"ioi260012r37","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s11136-009-9494-y","article-title":"Measuring patient satisfaction in oncology palliative care: psychometric properties of the FAMCARE-patient scale.","volume":"18","author":"Lo","year":"2009","journal-title":"Qual Life Res"},{"issue":"6","key":"ioi260012r38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2024.10398","article-title":"Stepped palliative care for patients with advanced lung cancer: a randomized clinical trial.","volume":"332","author":"Temel","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"ioi260012r39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1200\/JCO.2016.70.5046","article-title":"Ryan DP. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial.","volume":"35","author":"Temel","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8","key":"ioi260012r40","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer.","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"ioi260012r41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification.","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"ioi260012r42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejim.2019.09.004","article-title":"Health-related quality of life in patients with compensated and decompensated liver cirrhosis.","volume":"70","author":"Labenz","year":"2019","journal-title":"Eur J Intern Med"},{"key":"ioi260012r43","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jhep.2020.11.042","article-title":"The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs.","volume":"75","author":"Jepsen","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"ioi260012r44","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/annonc\/mdj072","article-title":"Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma.","volume":"17","author":"Steel","year":"2006","journal-title":"Ann Oncol"},{"issue":"7","key":"ioi260012r45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cgh.2010.03.008","article-title":"Health-related quality of life in patients with hepatocellular carcinoma: a systematic review.","volume":"8","author":"Fan","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"ioi260012r46","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/hep.32378","article-title":"AASLD Practice Guidance: palliative care and symptom-based management in decompensated cirrhosis.","volume":"76","author":"Rogal","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"ioi260012r47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1525-1497.2005.40135.x","article-title":"Continuity of care and other determinants of patient satisfaction with primary care.","volume":"20","author":"Fan","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"14","key":"ioi260012r48","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/heartjnl-2015-308638","article-title":"Effects of a transitional palliative care model on patients with end-stage heart failure: a randomised controlled trial.","volume":"102","author":"Wong","year":"2016","journal-title":"Heart"},{"issue":"3","key":"ioi260012r49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jacc.2017.05.030","article-title":"Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial.","volume":"70","author":"Rogers","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ioi260012r50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaneurol.2019.4992","article-title":"Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial.","volume":"77","author":"Kluger","year":"2020","journal-title":"JAMA Neurol"},{"issue":"3","key":"ioi260012r51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/jpm.2019.0349","article-title":"Comparing specialty and primary palliative care interventions: analysis of a systematic review.","volume":"23","author":"Ernecoff","year":"2020","journal-title":"J Palliat Med"},{"issue":"8","key":"ioi260012r52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004436","article-title":"Benefits of specialist palliative care by identifying active ingredients of service composition, structure, and delivery model: a systematic review with meta-analysis and meta-regression.","volume":"21","author":"Johnson","year":"2024","journal-title":"PLoS Med"},{"issue":"2","key":"ioi260012r53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11901-021-00562-0","article-title":"Creating effective models for delivering palliative care in advanced liver disease.","volume":"20","author":"Verma","year":"2021","journal-title":"Curr Hepatol Rep"},{"issue":"10008","key":"ioi260012r54","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(15)00680-7","article-title":"Implementation of the lancet standing commission on liver disease in the UK.","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"ioi260012r55","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003781","article-title":"Increasing goals of care discussions among veterans with cirrhosis: a Veterans Health Administration quality improvement initiative.","author":"Patel","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"ioi260012r56","article-title":"Palliative care for advanced liver disease: hepatology and palliative care specialists experiences.","author":"Hoppmann","year":"2025","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"ioi260012r57","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/0269216318760441","article-title":"Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist.","volume":"32","author":"Kimbell","year":"2018","journal-title":"Palliat Med"},{"issue":"14","key":"ioi260012r58","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/jama.2020.14205","article-title":"Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness: a systematic review and meta-analysis.","volume":"324","author":"Quinn","year":"2020","journal-title":"JAMA"},{"key":"ioi260012r5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/B978-0-323-84702-5.00044-0","volume-title":"Evidence-Based Practice of Palliative Medicine, Second Edition","author":"Rakoski","year":"2023"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2847656\/jamainternal_verma_2026_oi_260012_1780070178.15586.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:00:32Z","timestamp":1780326032000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2847656"}},"subtitle":["A Cluster Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2026.0571","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}